Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • Expanding the toolkit for design of robust phage therapeutic cocktails. Anne Kathryn Kauffman (Principal Investigator), Frank Scannapieco (Co-Investigator). NIH. $438,625. 12/1/2020-11/1/2022.
  • Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
  • MTM 2: Collaborative Research: How does phage life history strategy govern predation in microbiomes?. Anne Kathryn Kauffman (Co-Investigator). NSF. $848,751. 9/1/2020-8/1/2025.
  • Antibody-based therapeutic to target RAGE. Ding Xu (Principal Investigator). Buffalo Innovation Accelerator Fund. $90,000. 9/1/2020-8/1/2021.
  • A Novel Approach to Bradycardia during Preterm Neonatal Resuscitation Using an Ovine Model of Asphyxia. Praveen Chandrasekharan (Principal Investigator). ZOLL Foundation. $50,000. 7/1/2020-7/1/2022.
  • Genetic susceptibility to mucosal infections with aging. Elsa Bou Ghanem (Co-Principal Investigator). NIAID-R21. $438,625. 6/1/2020-5/1/2022.
  • Mitochondrial dynamics in SARS-CoV-2 spike protein treated human CNS cells: Implications for COVID19 induced CNS hypoxia. Supriya Mahajan (Principal Investigator). SUNY Research Seed Grant Program. $5,000. 6/1/2020-10/1/2020.
  • Pharmacokinetic Strategies to Increase Monoclonal Antibody Uptake, Distribution, and Efficacy for Treatment of Solid Tumors. Joseph Balthasar (Principal Investigator). NCI. $1,814,481. 6/1/2020-5/1/2025.
  • Bioinformatic Approaches for Understanding Macrophage Plasticity and Microbiome in Oral Diseases. Keith Kirkwood (Principal Investigator). national Institutes of Health. $94,393. 4/1/2020-3/1/2021.
  • Keith Kirkwood (Co-Investigator). national Institutes of Health. $275,000. 4/1/2020-3/1/2022.
  • Mechanisms of Heat Sensing by Nociceptive Vanilloid Receptors. Feng Qin (Principal Investigator). NIH. $2,684,432. 4/1/2020-3/1/2025.
  • Immunologic and clinical studies on perinatal hepatitis C viral infection. Karl O. Yu (Principal Investigator). Wildermuth Foundation. $35,000. 4/1/2020-3/1/2021.
  • CTSA Pilot: Lung and breast cancer prevention by an integrated intervention of maternal smoking cessation and breastfeeding. Xiaozhong Wen (Principal Investigator). NIH/NCATS. $45,000. 4/1/2020-3/1/2021.
  • Maternal Oxysterol Metabolism During Pregnancy. Xiaozhong Wen (Co-Investigator). NIH/NCATS. $40,000. 4/1/2020-3/1/2021.
  • Regulation of mRNA decay in retinal development and maintenance. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,024,085. 4/1/2020-3/1/2024.